Founded in 1995, SOSV is a global venture capital firm headquartered in New Jersey. It focuses on seed-to-growth stage investments in deep tech innovations, primarily in bio-tech/life sciences and hardware/robotics sectors, with a commitment to human and planetary health.

Established in 2020, the European Innovation Council supports innovative startups and researchers with promising ideas, focusing on early-stage companies with positive environmental, social, or governance impacts. It co-invests alongside private investors.

Founded in 2000, General Catalyst is a venture capital firm specializing in early-stage and growth equity investments. It focuses on accelerating ideas, careers, and companies towards success by providing ongoing momentum and mentorship based on deep experience.

Khosla Ventures is a California-based venture capital firm founded in 2004 by Vinod Khosla. It provides capital and strategic guidance to startups across stages, focusing on technology-driven companies in areas such as artificial intelligence, climate and sustainability, enterprise software and services, fintech, digital health, medical technology and diagnostics, therapeutics, consumer products, and frontier technologies. The firm backs bold ventures with the potential to disrupt markets and improve lives, supporting companies from early to growth stages and working closely with entrepreneurs to apply science, technology and innovative business models. While primarily investing in North American technology companies, Khosla Ventures pursues opportunities globally and emphasizes experimentation and impact alongside financial returns. The firm also maintains related impact initiatives that support entrepreneurs addressing socio-economic challenges in emerging markets.

Right Side Capital Management is a San Francisco-based venture capital firm that focuses on early-stage, pre-seed technology startups in underserved segments of the ecosystem. It invests in a high-volume, capital-efficient portfolio, typically funding rounds of 50,000 to 500,000 and making roughly 75 to 100 investments per year. The firm targets opportunities across the United States and internationally, including Canada, Israel, Australia, New Zealand, and Western Europe, prioritizing companies with scalable products and prudent capital use outside major metro hubs. Since its inception, it has built a broad portfolio across many states. It commits to a fast decision process, often delivering a yes or no within two weeks to help founders establish momentum.

Qiming Venture Partners is a China-based venture capital firm founded in 2006, with offices in Shanghai, Beijing, Suzhou, Hong Kong and Singapore, and a global arm through Qiming Venture Partners USA. It manages multiple funds and invests in early and growth-stage companies across technology, information technology, healthcare, new consumer sectors, AI, robotics, semiconductors, software and digital health. The firm emphasizes a hands-on approach, often taking board seats and providing operational guidance to help CEOs scale and reach exits. Through its investments, it has backed hundreds of companies and supported numerous IPOs and M&A outcomes, with unicorns among its portfolio, illustrating breadth and depth across China and international markets.

Alumni Ventures Group is a venture capital firm based in Manchester, New Hampshire, with offices across North America. It provides access to venture investing for individual accredited investors, particularly alumni networks, by offering diversified portfolios of venture opportunities and allowing members to invest alongside fellow alumni in ventures led by peers. The firm backs early-stage and later-stage opportunities across technology, consumer, healthcare, financial services, and other sectors, with a sector- and geography-agnostic approach. It typically invests between $10,000 and $3 million per deal and emphasizes the involvement of alumni connections and an institutional lead investor in opportunities. Alumni Ventures also offers focused funds to broaden participation, enabling accredited investors to access venture portfolios diversified by type, sector, stage, and geography. The model aims to democratize access to venture capital while maintaining rigorous selection standards through alumni networks.

Founded in Singapore in 2017, Antler is an early-stage venture capital firm that invests globally. It focuses on backing exceptional founders from day one, offering a global community network of co-founders, talent, advisors, expansion support, and capital across various sectors such as technology, healthcare, finance, consumer goods, and more.

Founded in 2011, StartUp Health is dedicated to improving global health through collaboration with entrepreneurs. It invests in 'Health Transformers' across six continents, focusing on various health moonshots such as Access to Care, Cure Disease, and Mental Health. With over 330 companies in its portfolio, it's backed by prominent investors.

Ben Franklin Technology Partners of Southeastern Pennsylvania is a technology-focused capital provider based in Philadelphia, founded in 1982 to advance the region's technology community. The organization funds and supports technology companies across Pennsylvania, especially in information technology, health, and physical sciences, investing substantial capital in early-stage and established ventures. It has invested over 170 million dollars in more than 1,750 regional technology companies and has launched university-industry partnerships to translate scientific discoveries into commercial products, while seeding regional initiatives that strengthen the entrepreneurial ecosystem and create jobs.

SFC Capital is a United Kingdom based venture capital firm founded in 2012 that focuses on early-stage investments, including pre-seed and seed rounds, in sectors such as software, technology, e-commerce, consumer products, enterprise solutions, green technology, medical technology, and hospitality. It backs UK startups through an Angel Network and seed funds, providing capital and guidance and offering access to SEIS- and EIS-qualifying investment opportunities. The firm is described as a leading seed investor in the UK.

High-Tech Gründerfonds Management GmbH is a venture capital firm based in Bonn, Germany, specializing in early-stage investments in high-tech startups. Established in 2005, the firm focuses on technology-driven companies across various sectors, including information and communication technology, life sciences, healthcare, automation, and cleantech. HTGF typically invests in companies that have been operational for no more than one year, aiming to contribute up to €0.6 million in initial funding and up to €3 million in follow-on financing. The firm seeks a minority stake, generally around 15%, and provides a subordinated loan convertible into equity, with deferred interest for up to four years to support liquidity. With a total investment volume of approximately €895.5 million across three funds, HTGF has successfully supported over 500 startups and attracted more than €2 billion in follow-on investments from external sources. The firm's investors include notable public and private entities, underscoring its role as a key player in fostering innovation and growth within the German startup ecosystem.

Founded in 1969, F-Prime Capital is a venture capital firm based in Cambridge, Massachusetts. It invests globally in technology and healthcare sectors, supporting entrepreneurs with its extensive domain expertise and relationships.

Founded in 1989, OrbiMed is a New York-based healthcare-dedicated investment firm managing approximately $5 billion in assets. It invests across the spectrum of healthcare companies, from private start-ups to large multinational corporations, focusing on biopharmaceuticals, life sciences, digital health, medical devices, and diagnostics sectors globally.

Andreessen Horowitz is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz and based in Menlo Park, California. It funds startups across the entire lifecycle, from seed to growth, with a broad focus on software and technology-enabled businesses. The firm backs companies in software, cloud infrastructure, digital platforms, data storage, and mobile and Internet services, as well as sectors at the intersection of technology with life sciences, such as bio healthcare and computational medicine. Its investments span artificial intelligence, fintech, consumer and enterprise software, crypto and blockchain, cybersecurity, and related infrastructure. Through strategic guidance and a hands-on approach, the firm aims to help portfolio companies scale and innovate.

Founders Fund is a San Francisco-based venture capital firm that backs science and technology companies across multiple stages, from seed to late-stage. It pursues transformative technologies and follows a founder-friendly investment approach that provides substantial support with minimal interference. The firm invests in ventures solving difficult problems across sectors such as aerospace and transportation, artificial intelligence, advanced computing, energy, healthcare, biotechnology, cybersecurity, fintech, consumer internet, software, robotics, and related technology fields. It has backed notable companies early, including SpaceX, Palantir, and Facebook, reflecting a history of partnering with ambitious founders to scale breakthrough technologies.

Sequoia Capital Israel is a venture capital firm that backs startups and growth companies across seed to late-stage rounds, with a focus on Israel. It invests across sectors including fintech, financial services, internet, mobile, technology, and healthcare, spanning banking, payments, advertising, ecommerce, data, security, software, and related enabling tech. Typical commitments range from 100,000 to 1 million in seed, 1 to 10 million in early venture, and 10 to 100 million in growth rounds. The firm is based in Tel Aviv and operates as part of Sequoia Capital's global network.

8VC is a technology and life sciences investment firm that partners with founders to develop transformational technologies and create long-term value. Its activities span sectors such as healthcare, logistics, software, energy, manufacturing, enterprise IT, and life sciences, with a focus on supporting early-stage and growth opportunities in the United States and beyond.

Founded in 2014, Gaingels is a venture investment syndicate dedicated to supporting the LGBT+ community. It invests globally in companies led by LGBT+ founders or C-suite executives at all stages of growth, focusing on inclusivity and positive social change.

Northpond Ventures is a science-driven venture capital firm based in Bethesda, Maryland, with additional offices in San Francisco, California, and Cambridge, Massachusetts. Founded in 2018, the firm concentrates its investments in life sciences, diagnostics, therapeutics, digital health, and related technologies, including AI and machine learning applications in biotech and medical fields, as well as environmental and other emerging technologies. It seeks to back early- and growth-stage companies that advance biomedical research, diagnostics, medical devices, and technology-enabled health solutions. The firm operates as a registered investment adviser and emphasizes building a better tomorrow through science-driven investing. It focuses on strategy, value creation, and supporting companies at the intersection of life sciences and technology, aiming to accelerate innovations that improve health outcomes.

Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011, that manages investment portfolios and provides asset management services to clients across sectors, with a focus on software as a service companies, and analyzes market trends to inform its investment decisions while operating in finance, technology, and real estate.

Sequoia Capital is a venture capital firm founded in 1972 and based in Menlo Park, California. It invests in seed, early, and growth-stage companies across technology, energy, financial services, healthcare, internet, mobile, outsourcing, manufacturing, media, and retail sectors. The firm seeks ambitious founders and aims to help them build long-lasting, scalable businesses, often taking the lead or significant co-investor roles and providing strategic guidance, networks, and resources. It maintains an international footprint, including investments in India and other regions, reflecting a global approach to partnering with fast-growing companies. Sequoia emphasizes strong teams, innovative products or services, and the potential for rapid growth, positioning itself as a long-term partner for companies that redefine their markets.

New Enterprise Associates is a venture capital firm founded in 1977 and based in Menlo Park, California, with offices in the United States, India and China. It makes investments across technology and healthcare startups at multiple stages, from seed to growth, including software, cloud, data, internet services, fintech, AI, e-commerce, and enterprise technology, as well as healthcare information technology, life sciences, medical devices, and biopharma. It also considers energy technology and infrastructure opportunities, such as solar, batteries and smart grids. The firm pursues a global approach, with activity in the United States, Asia and other regions, and supports companies through rounds of financing ranging from small to sizable investments as they scale. NEA focuses on building portfolios in software, IT services, consumer technology, and healthcare technology, backing ambitious entrepreneurs across sectors and geographies.

HealthTech Capital is an angel investment group based in Los Altos Hills, California, founded in 2010. The group focuses on funding and mentoring emerging health-tech startups that operate at the intersection of healthcare, technology, and mobility. By fostering collaboration among leading clinical providers, venture firms, and other strategic industry players, HealthTech Capital aims to create a robust ecosystem that supports innovative solutions in the health sector.

Founded in 1986, ARCH Venture Partners is a venture capital firm specializing in investments that bring innovations in life sciences to market. It focuses on companies co-founded by scientists and entrepreneurs, with a strong track record in commercializing technologies from academic research institutions and national laboratories.

Founded in 2014, Goodwater Capital is a venture capital firm based in Burlingame, California. It invests in early-stage consumer technology companies, empowering exceptional entrepreneurs to solve pressing problems and create global impact.

Founded in 2000, Lux Capital is a venture capital firm based in New York and Silicon Valley. It manages over $5 billion in assets, focusing on seed to growth investments at the intersection of technology and sciences. Lux actively supports entrepreneurs building successful businesses in high-growth sectors such as biochemistry, material science, electronics, infrastructure, aerospace, genomics, synthetic biology, and robotics.

Founded in 2015, FJ Labs is a New York-based venture capital firm focusing on stage-agnostic investments in marketplaces and consumer-facing startups. Their investment range varies from $50,000 to $5,000,000, typically at seed or series A stages.

Founded in 2010, Verve Ventures is a European venture capital firm headquartered in Switzerland. It operates a digital investment platform for qualified investors, enabling them to build diversified startup portfolios with investments starting at EUR 10,000. With over EUR 130 million invested in over 100 startups and a community of 5,000 registered investors, Verve Ventures focuses on science and technology sectors, sourcing top deals and structuring rounds for its investors.

Founded in 2009 and based in New York City, BoxGroup is an early-stage investment fund focusing on pre-seed to Series A rounds. It invests globally, with a primary focus on New York City, Silicon Valley, and Los Angeles. The firm typically allocates between $50,000 and $250,000 per investment across various sectors including consumer, enterprise, fintech, healthcare, life science, marketplace, synthetic biology, and climate.

Founded in Boston in 2004, RA Capital is an investment firm specializing in life sciences and drug development. Its team, with backgrounds in biology, chemistry, medicine, and industry experience, invests in early-stage companies with promising technologies and products across healthcare and life science sectors.

Kurma Partners is a Paris-based investment firm founded in 2009 that concentrates on financing innovation in healthcare and biotechnology across Europe. It targets early-stage and development capital for companies in life sciences, biotechnology, digital health, and related fields, and emphasizes collaborations with research institutes and hospitals to advance therapies and medical technologies from concept to clinical development. The firm operates as a specialist investor in Europe, supporting ventures that bridge scientific discovery and patient impact through equity investments and strategic guidance.

Optum is a healthcare services and innovation company dedicated to improving health outcomes. It offers a range of services including family medicine, mental health care, and specialized therapies for rare diseases. Optum also provides healthcare financial services and technology solutions to health plan providers.

Oak HC/FT is a venture and growth equity investment firm specializing in healthcare information services and financial technology. It supports portfolio companies with strategic counsel, board-level participation, and access to a broad network of industry leaders to drive transformation in these sectors. The firm, based in Stamford, Connecticut, operates within the Oak Investment Partners family, leveraging sector-specific expertise from Oak's healthcare and fintech teams to build and scale innovative businesses.

Established in 1999, Innovation Works is a prominent investor in Southwestern Pennsylvania's technology sector. It provides capital and resources to early-stage companies with high growth potential and significant regional impact, particularly focusing on robotics, AI, medical devices, retail technologies, and enterprise software.

Founded in 1863, Mayo Clinic is a non-profit organization based in Minnesota, United States. It provides comprehensive medical care services across various specialties, conducts extensive research, and offers education in clinical medicine.

Eli Lilly and Company is a global pharmaceutical leader engaged in the discovery, development, manufacture, and sale of medicines. It operates facilities in the United States, Puerto Rico, and many other countries, with products sold in about 135 countries. The company focuses on therapies in neuroscience, cardiometabolic, cancer, and immunology, and also conducts research in animal health and animal agriculture. Lilly supports patient outcomes and education through a philanthropic foundation that funds programs in underserved communities, including STEM education in Indianapolis.

Morningside is a venture capital firm based in the greater Boston area, specializing in investments in companies that focus on innovative science and technology. Established in 1986 as a family office for the Chan family, Morningside emphasizes a long-term approach to company-building and maintains a strong commitment to ethical practices. The firm is staffed by a team of experienced investment professionals with expertise in various sectors, including life sciences, digital health, artificial intelligence, materials, and technology. In addition to its investment activities, Morningside is dedicated to philanthropic efforts, supporting education, research, and healthcare initiatives such as the Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design.

Founded in Sweden in 2009, Almi Invest is an active early-stage venture capital firm focusing on scalable startups across Sustainability, Industry, Tech, and Life Science sectors. With €430 million under management and over 1,000 investments since inception, the company supports startups from pre-seed to Series A stages, co-investing with private investors. Almi Invest offers engaged ownership, strategic guidance, active board participation, and access to an extensive investor network.

BioVenture, established in September 2013, specializes in early-stage venture capital investments in the field of life sciences, focusing on biotechnology, drug discovery, medical devices, and healthcare services companies. With a fund size of 540 million yuan, BioVenture provides capital and post-investment support to innovative companies with high growth potential. Backed by Suzhou Industrial Park and BioBay, BioVenture aims to become one of China's most successful medical and pharmaceutical venture funds by leveraging its industry expertise and resources. The team at BioVenture consists of senior investment professionals with deep knowledge of domestic and foreign markets, aiming to help companies grow rapidly and achieve greater success while delivering considerable returns to fund investors. Through joint venture development cooperation, BioVenture seeks to drive innovation and growth in the medical and pharmaceutical industry.

Pioneer Fund is a San Francisco-based venture capital firm founded in 2017 that makes early-stage investments across a wide range of sectors, including consumer products and services, financial services, information technology, advanced manufacturing, blockchain, life sciences, gaming, artificial intelligence and machine learning, construction technology, education technology, fintech, agriculture technology, advertising technology, augmented reality, autonomous vehicles, legal technology, oncology, pet technology, real estate technology, ride-hailing, SaaS and supply chain technology. The firm benefits from a network of more than 420 Y Combinator alumni, enabling it to identify and support YC-backed startups.

Founded in 1986, Morningside Group is a venture capital firm based in the greater Boston area. It invests in companies with innovative science and technology across life sciences, digital health, AI, materials, and technology sectors.

Founded in Rome, Italy in 2015, CDP Venture Capital is a venture capital firm dedicated to fostering innovation and economic growth. It invests in early-stage and growth companies across various sectors, with a focus on Italian startups.

Nina Capital is an international venture capital firm focused on healthcare transformation powered by information technology. It concentrates on pre-seed and seed-stage investments and is guided by deep industry experience and need-driven founders. The firm supports health tech solutions that aim to deliver lasting improvements in healthcare delivery and outcomes. Its diverse, multinational, and multidisciplinary team is led by former healthcare technology founders and operators, bringing together expertise from multiple healthcare and technology sectors. Founded in 2019 and based in Barcelona, Spain, Nina Capital has invested in companies across nearly 20 countries and has contributed to healthcare technology innovations that have touched the lives of more than 10 million people.

Deerfield Management is a New York-based investment firm established in 1994 that focuses on healthcare. It operates across investment, information, and philanthropy to support the healthcare ecosystem. The firm provides private and public investments and offers long-term, structured capital to both public and private healthcare companies. Its portfolio spans life sciences, medical devices, diagnostics, digital health, and health services. As an investment adviser, it seeks opportunities in healthcare products and services and aims to accelerate innovation by combining capital with industry insight.

Founded in London in 2016, Future Planet Capital is a venture capital firm investing in growth-stage companies from top global universities. It focuses on breakthrough technologies addressing challenges in climate change, health, education, and sustainable growth.

Founded in 2015, Liquid 2 Ventures is a venture capital firm based in San Francisco, California. It specializes in seed-stage investments for technology startups.

7wire Ventures is a Chicago-based venture capital firm founded in 2011 that concentrates on early-stage investments in digital health, healthcare IT, mobility-enabled services, and other technology-enabled solutions in the United States. The firm provides funding and operating guidance to portfolio companies to help transform innovative ideas into scalable, world-class businesses. Its approach leverages mobility, connected devices, cloud computing, and analytics to advance sectors such as healthcare and education and to challenge conventional solutions.

Accel is a venture capital firm founded in 1983 and based in Palo Alto, California, with additional offices in San Francisco, London, and Bangalore. It focuses on early and growth-stage technology startups, investing across software, cloud, data analytics, mobile technology, consumer services, fintech, security, healthcare, and information technologies. Accel seeks to partner with entrepreneurs to build world-class companies that define new categories and drive growth. Its portfolio includes notable technology companies such as Atlassian, Dropbox, Slack, Spotify, Etsy, Cloudera, DJI, Braintree, and Lookout Security, among others.

First Round Capital is a San Francisco-based venture capital firm that concentrates on seed- and early-stage investments, often supporting pre-revenue startups across sectors including enterprise software, fintech, healthcare, consumer, hardware, artificial intelligence, and web3. The firm emphasizes a community-driven approach, providing founder-focused services, mentorship, and access to a broad founder network to help companies grow. It operates nationally with offices in San Francisco and New York and seeks to take an active role in portfolio companies to aid scaling and access to follow-on funding.